Dennis W Trent

Title: Dennis W. Trent: Innovator in Reverse Transcriptase Detection

Introduction

Dennis W. Trent is a notable inventor based in Carbonniers, France. He has made significant contributions to the field of biotechnology, particularly in the detection of reverse transcriptase activity in eukaryotic cell lines. His work is crucial for ensuring the safety of biological products, including viral vaccines.

Latest Patents

Dennis W. Trent holds a patent for the invention titled "CoRT-PCR assay for the discrimination of endogenous reverse transcriptase activity in eukaryotic cell lines from infectious retrovirus contamination." This patent relates to a method for detecting the presence of reverse transcriptase enzymatic activity in eukaryotic cell lines. The invention specifically addresses the need to differentiate between endogenous reverse transcriptase activity and exogenous infectious retrovirus. By employing a combination of transmissibility assays and PBRT assays, the method allows for the detection of exogenous infectious reverse transcriptase activity while avoiding false positives from endogenous sources.

Career Highlights

Throughout his career, Dennis has been associated with Aventis Pasteur Limited, a leading company in the field of vaccines and biological products. His innovative approach to reverse transcriptase detection has positioned him as a key figure in ensuring the safety and efficacy of vaccines.

Collaborations

Dennis has collaborated with notable colleagues, including Scott J. Goebel and Maurice Harmon. Their combined expertise has contributed to advancements in the field of biotechnology and the development of safer biological products.

Conclusion

Dennis W. Trent's contributions to the detection of reverse transcriptase activity have had a significant impact on the biotechnology industry. His innovative methods enhance the safety of biological products, ensuring public health and advancing scientific research.